Effect of Pentoxifylline on Proteinuria in Korean Type 2 Diabetic Patients
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 174 participants.
Also called NCT01382303
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 174 participants
- Sponsor
- Registry
-
NCT01382303
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- South Korea
- Registry status
- Completed
Technical summary
Registry record NCT01382303. Randomized; double masking; primary purpose treatment. Start 2010-10-25 (actual); primary completion 2013-12-20 (actual). Results posted on 2017-06-16.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Effect of Pentoxifylline on Proteinuria in Korean Type 2 Diabetic Patients
- Condition
- Type 2 Diabetes
- Intervention (Drug)
- Pentoxifylline
- Intervention (Drug)
- Placebo
- Lead sponsor
- Ajou University School of Medicine
- Collaborator
- Bundang CHA Hospital
- Collaborator
- Hallym University Medical Center
- Collaborator
- Gangnam Severance Hospital
- Collaborator
- Yonsei University
- Collaborator
- Myongji Hospital
Record details
- Record id
cardio:ct-nct01382303- Content hash
8c0981387f113530e09c595476973650c58f2a2110c6563e36150e3c0600311d